In the evaluation of a patient with rapidly progressive glomerulonephritis (RPGN) showing crescents in >50% of glomeruli, immunofluorescence reveals linear IgG deposits along the GBM. Anti-GBM antibody ELISA is strongly positive. Which domain of which molecule do the pathogenic antibodies target, and why does this cause such rapid crescent formation compared to other RPGN types?

• A Antibodies target alpha-3 chain of type IV collagen (the NC1 domain), the predominant isoform in the GBM; antigen accessibility in GBM and alveolar basement membrane explains the rapidity of injury, as there is no antigen consumption unlike immune complex diseases ✓
• B Antibodies target nephrin at the slit diaphragm; continuous antigenic stimulation from protein leakage drives persistent antibody production
• C Antibodies target heparan sulfate proteoglycan in the GBM; loss of negative charge causes protein leakage that activates macrophages directly
• D Antibodies target alpha-1 chain of laminin; complement-independent direct GBM lysis accounts for rapid fibrin deposition

Explanation

Anti-GBM disease (Goodpasture syndrome) involves autoantibodies targeting the non-collagenous-1 (NC1) domain of the alpha-3(IV) collagen chain, which is the predominant type IV collagen variant in GBM and alveolar basement membrane. The pathogenic epitopes are normally cryptic (hidden by alpha-1/alpha-2 chain interactions within the triple helix) but become exposed by infections, hydrocarbons, or smoking. The antigen is persistent and structural (non-renewable), and direct antibody binding activates complement and recruits neutrophils, causing rapid parietal epithelial cell proliferation to form crescents. Crescent formation can occur within days, making it the most rapidly progressive form of RPGN.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.